Search / 130 results found

from
to
AP
  • Updated

FILE - This Feb. 5, 2021, file photo shows the Pfizer logo displayed at the company's headquarters in New York. Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (AP Photo/Mark Lennihan, File)

AP
  • Updated

FILE - In this Feb. 5, 2021, file photo, the Pfizer logo is displayed at the company's headquarters in New York. Pfizer asked the U.S. government Thursday, Oct. 7, 2021, to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks. (AP Photo/Mark Lennihan, File)

AP
  • Updated

FILE - In this Aug. 2, 2021, file photo, COVID ward healthcare worker watches from behind his face shield, double masks and full personal protective equipment as he works with a COVID-19 patient at Our Lady of the Lake Regional Medical Center in Baton Rouge. COVID-19 deaths in the U.S. are coming down again, hospitalizations are dropping, and new cases per day are about to dip below 100,000 for the first time in two months — all signs that the summer surge is waning. (AP Photo/Ted Jackson, File)

AP
  • Updated

A vaccination campaign against the coronavirus is underway at a Tripoli shelter for migrants, organized jointly by the Libyan center for disease control and the International Organization for Migration. in Tripoli, Libya, Wednesday Oct. 6, 2021. (AP Photo/Yousef Murad)

AP
  • Updated

A vaccination campaign against the coronavirus is underway at a Tripoli shelter for migrants, organized jointly by the Libyan center for disease control and the International Organization for Migration. in Tripoli, Libya, Wednesday Oct. 6, 2021. (AP Photo/Yousef Murad)